| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 06/04/2002 | US6399053 Methods of enhancing bioactivity of chemokines |
| 06/04/2002 | CA2237805C Nucleic acid molecule encoding a 11-cis retinol dehydrogenase |
| 06/04/2002 | CA2171424C Acylated insulin |
| 06/04/2002 | CA2084384C Dna coding for uricase and process for producing uricase |
| 06/04/2002 | CA2011450C Recombinant b-chain of the il-2 receptor |
| 06/04/2002 | CA1341364C Single polypeptide chain binding molecules |
| 06/01/2002 | CA2325088A1 Novel membrane fusion proteins derived from poikilothermic reovirus |
| 05/30/2002 | WO2002042776A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/30/2002 | WO2002042767A2 Step-wise process to recover or eliminate biological substances by flotation from underlayered colloidal medium |
| 05/30/2002 | WO2002042474A1 Zygomycetes-origin endoglucanase lacking cellulose-binding domain |
| 05/30/2002 | WO2002042472A1 Nucleotide sequences which code for the mtra and mtrb gene |
| 05/30/2002 | WO2002042471A2 Methods and materials for the synthesis of organic products |
| 05/30/2002 | WO2002042470A1 Isolated luciferases and the use thereof |
| 05/30/2002 | WO2002042469A1 Isolated luciferases lu164, lual and lu22, and the use of the same |
| 05/30/2002 | WO2002042467A2 Aspergillus fumigatus profilin |
| 05/30/2002 | WO2002042466A2 Nucleotide sequences coding for the cysq gene |
| 05/30/2002 | WO2002042463A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/30/2002 | WO2002042462A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 05/30/2002 | WO2002042461A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 05/30/2002 | WO2002042456A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | WO2002042455A2 Modifier of organelle metalbolism |
| 05/30/2002 | WO2002042451A2 Aspergillus fumigatus cofilin |
| 05/30/2002 | WO2002042447A2 Surface transfection and expression procedure |
| 05/30/2002 | WO2002042444A2 Fungal gene cluster associated with pathogenesis |
| 05/30/2002 | WO2002042442A2 Yeast strain for consumption |
| 05/30/2002 | WO2002042437A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/30/2002 | WO2002042436A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
| 05/30/2002 | WO2002042435A2 Regulation of human tyrosine phosphatase |
| 05/30/2002 | WO2002042419A2 Cell culture apparatus and methods of use |
| 05/30/2002 | WO2002042418A2 3-hydroxypropionic acid and other organic compounds |
| 05/30/2002 | WO2002042417A2 Human erg2 potassium channel |
| 05/30/2002 | WO2002042330A2 Cystoskeleton-associated proteins |
| 05/30/2002 | WO2002042324A1 Gene encoding protein cluster i and the encoded protein |
| 05/30/2002 | WO2002028423A8 Stabilisation of plasmid inheritance in bacteria by preventing multimerisation |
| 05/30/2002 | WO2002022782A3 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 05/30/2002 | WO2002022633A3 Nucleotide sequences which code for the atr61 gene |
| 05/30/2002 | WO2002020799A3 Nucleotide sequences which code for the luxs gene |
| 05/30/2002 | WO2002020736A9 Proteases |
| 05/30/2002 | WO2002018581A9 G-protein coupled receptors |
| 05/30/2002 | WO2002018438A9 Modified proteins, isolated novel peptides, and uses thereof |
| 05/30/2002 | WO2002008412A3 Use of cyp52a2a promoter to increase gene expression in yeast |
| 05/30/2002 | WO2002000895A3 Bordetella bronchiseptica mutant which produces recombinant pertussis toxin and uses thereof |
| 05/30/2002 | WO2002000663A3 Polycyclic xanthones as antibiotics |
| 05/30/2002 | WO2001096577A8 Production of secreted polypeptides |
| 05/30/2002 | WO2001094562A3 Cold sensitive mutant dna polymerases |
| 05/30/2002 | WO2001094380A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | WO2001087979A3 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci |
| 05/30/2002 | WO2001081413A3 Isolated human transporter proteins, nucleic acids and uses thereof |
| 05/30/2002 | WO2001068704A3 G-protein coupled receptors |
| 05/30/2002 | WO2001066776A3 Novel l-form bacterial strains, method for producing same and the use thereof for producing gene products |
| 05/30/2002 | WO2001066746A3 G-protein coupled receptor related polypeptides |
| 05/30/2002 | WO2001064877A3 Human schizophrenia gene |
| 05/30/2002 | WO2001048187A3 A molecular switch for regulating mammalian gene expression |
| 05/30/2002 | WO2001044816A3 Conformational and topological protein regulation |
| 05/30/2002 | WO2001042509A9 Use of multiple recombination sites with unique specificity in recombinational cloning |
| 05/30/2002 | WO2001038511A8 Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells |
| 05/30/2002 | WO2001029063A8 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 05/30/2002 | WO2000078952A8 Human rna metabolism proteins (rmep) |
| 05/30/2002 | US20020066120 Plant myb-related transcription factors |
| 05/30/2002 | US20020065538 Method and device for recording polarized electromagnetic radiation of inactivated strain of pathogenic microorganisms onto a crystal, method and device for changing activity of strain of pathogenic microorganisms, method for eliminating strain of pathogenic microorganisms from human or animal organism |
| 05/30/2002 | US20020065496 Absorbent article for controlling normal flora of the skin |
| 05/30/2002 | US20020065403 New nucleotide sequences which code for pck gene |
| 05/30/2002 | US20020065393 Human hypoxanthine- (guanine) phosphoribosy1 transferase-2 |
| 05/30/2002 | US20020065392 Methods for production of protein |
| 05/30/2002 | US20020065316 Citrullimycines, a process for their production and their use as pharmaceuticals |
| 05/30/2002 | US20020065292 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting ERAB or HADH2 activity |
| 05/30/2002 | US20020065238 EPO primary response gene, EPRG3pt |
| 05/30/2002 | US20020065237 SBHWSB1 polypeptides/polynucleotides produced by recombinant techniques; gene therapy; diagnostic tests; agonists; antagonists; "positional cloning"; sequence of Serine(S), Aspargine/Asparic Acid(W), Histidine (H) and Tryptophan (T) |
| 05/30/2002 | US20020065220 For use in diagnosis and therapy of disorders treating disorders related to these novel human immunoglobulin-like (Ig- like) proteins |
| 05/30/2002 | US20020065210 DcR3 polypeptide, a TNFR homolog |
| 05/30/2002 | US20020064871 Endogenous ketogulonigenium plasmid |
| 05/30/2002 | US20020064869 Polypeptide for use in treatment of lymphadenopathy, autoimmune disease and graft versus host disease; antitumor agents |
| 05/30/2002 | US20020064865 Crystal protein for use in bological pest control |
| 05/30/2002 | US20020064864 Microbial composition and a process useful for the neutralization of alkaline waste-waters |
| 05/30/2002 | US20020064862 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |
| 05/30/2002 | US20020064859 Nuclelotide sequences coding heterologous protein for use in the treatment of cancer, infections, genetic and immunological disorder |
| 05/30/2002 | US20020064856 Novel proteases |
| 05/30/2002 | US20020064854 Enzymatic polypeptide for use in detergents for automatic dishwashers and laundry detergents |
| 05/30/2002 | US20020064851 Peptide for use in development of human diagnostics and therapeutics; for use in deection and treatment of cancer, inflammation, immune disorders and development defects |
| 05/30/2002 | US20020064850 Nucleotide sequences for use in generating fructose polymers for food processing |
| 05/30/2002 | US20020064848 Novel histidinol dehydrogenase |
| 05/30/2002 | US20020064846 Protein for use treatment of diabetes |
| 05/30/2002 | US20020064844 Nucleotide sequences coding enzymatic polypeptide for use in the diagnostic tool in detection, prevention and treatment of nervous system, reproductive and vascular systems disorders |
| 05/30/2002 | US20020064843 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/30/2002 | US20020064835 Generating muscle protein; obtain sample, incubate under reducing environment, recover muscle protein |
| 05/30/2002 | US20020064831 Nucleotide sequences coding polypeptides associated capillary morphogenesis; for use in controlling neovascularization; antitumor agents |
| 05/30/2002 | US20020064826 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 05/30/2002 | US20020064823 Nucleotide sequences which code binding protein for use in human therapeutics and gene therapy |
| 05/30/2002 | US20020064821 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 05/30/2002 | US20020064818 Nucleotide sequences coding preferential polypeptide; for use in diagnosis and treatment of cancer, nervous system, inflammatory and immunological disorders |
| 05/30/2002 | US20020064811 Dna encoding the human synapsin iii gene and uses thereof |
| 05/30/2002 | US20020064807 Diagnosing prokaryotic infectiins; obtain sample with prokaryote present, inoculate substrate, culture, evalute culture prokaryote |
| 05/30/2002 | US20020064786 Cancer diagnosis and therapy based on mutations in TGF-beta receptors |
| 05/30/2002 | US20020064535 Such as human granulocytic ehrlichiosis; polypeptides of antigenic portion(s) of an Ehrlichia antigen and DNA sequences encoding them; vaccines; detection kits |
| 05/30/2002 | US20020064531 P28 gene family, may be involved in immune avoidance; DNA sequences, proteins, antibodies; use in vaccines against E. chaffeensis |
| 05/30/2002 | US20020064525 Anti-IgE vaccines |
| 05/30/2002 | CA2439184A1 Aspergillus fumigatus cofilin |
| 05/30/2002 | CA2439164A1 Aspergillus fumigatus profilin |
| 05/30/2002 | CA2430270A1 Methods and materials for the synthesis of organic products |
| 05/30/2002 | CA2429860A1 Endogenous and non-endogenous versions of human g protein-coupled receptors |